3DBio Therapeutics, Inc.

Leaders in making therapeutic-grade bioprinting a reality for patients

3DBio Therapeutics is a biologics and bioprinting company with a focus on regenerative medicine that precision manufactures living tissues to allow replacement of each individual patient’s parts with tissues designed and created specifically for them.

3DBio Therapeutics Logo
November 19, 2019 in 3DBio Therapeutics, Inc., Portfolio

3DBio Therapeutics Receives Orphan Drug Designation for AuriNovo™ for Ear Reconstruction in Microtia Patients

NEW YORK, Nov. 19, 2019 /PRNewswire/ -- 3DBio Therapeutics, an emerging leader in the field of 3D-bioprinting for human therapeutic…
Read More
April 1, 2019 in 3DBio Therapeutics, Inc., Portfolio

3DBio Therapeutics Announces Appointment of Sol Barer, Ph.D. and Kevin Slawin, M.D. to Board of Directors

NEW YORK, April 2, 2019 /PRNewswire/ —  3DBio Therapeutics, an emerging leader in the field of 3D-bioprinting for human therapeutic use,…
Read More